Filtered By:
Specialty: Pharmaceuticals
Source: WSJ.com: Health
Condition: Heart Attack
This page shows you your search results in order of date.
Order by Relevance | Date
Total 7 results found since Jan 2013.
Study Suggests Heart Patients May Need Fewer Blood Thinners
Researchers said a study involving reduced doses of Johnson& Johnson ’s anticoagulant Xarelto suggests it may be possible for patients with two types of heart disease to avoid the need for three different blood thinners to protect them from stroke and heart attack.
Source: WSJ.com: Health - November 15, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
FDA Strengthens Warnings on Class of Painkillers
The FDA strengthened its safety warnings about heart-attack and stroke risks linked to a class of common pain relievers that includes medicines such as Celebrex, Advil, Motrin IB and Aleve.
Source: WSJ.com: Health - July 10, 2015 Category: Pharmaceuticals Tags: PAID Source Type: news
More Study Urged on Testosterone Drugs
A Food and Drug Administration panel recommended that makers of testosterone-replacement drugs study possible increased risks of heart attack and stroke from the hot-selling products.
Source: WSJ.com: Health - September 18, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news
FDA Probes Risks of Testosterone-Boosting Drugs
The FDA said it is investigating the possible increased risk of stroke, heart attack and death in men who are taking testosterone-boosting products for the condition widely called "low-T."
Source: WSJ.com: Health - January 31, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news
Testosterone Therapy Tied to Heart Risks
Testosterone therapy raised the risk of death, heart attack and stroke by about 30% in a group of veterans with a history of heart disease, according to a new study.
Source: WSJ.com: Health - November 6, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news
When Disease Can Bring On Stress Disorder
Post-traumatic stress disorder, or PTSD, most often associated with soldiers returning from the battle front, is increasingly being diagnosed in people with medical conditions from stroke and heart attack to cancer.
Source: WSJ.com: Health - June 24, 2013 Category: Pharmaceuticals Tags: FREE Source Type: news
